Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma

Fig. 1

Representative immunohistochemical stanning of CD44, CD44v6, CD44v8-10, CD133, EpCAM, and ALDH1A1 in normal bile duct, dysplasia and CCA. For CCA, negative or low membrane expression of CD44, CD44v6, CD44v8-10, CD133, EpCAM are shown in the upper panel and positive and high membrane expression in the lower panel, low cytoplasmic expression of ALDH1A1 is shown in the upper panel and high cytoplasmic expression in the lower panel

Back to article page